ArticleBMJ neurology open2023

Correlation of disability with quality of life in patients with multiple sclerosis treated with natalizumab: primary results and post hoc analysis of the TYSabri ImPROvement study (PROTYS).

Lutz Achtnichts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.